Biliary tract infections (BTI), often linked to structural abnormalities like bile duct stones, pose significant treatment challenges due to drug-resistant bacteria like Pseudomonas aeruginosa. Phage ...

Armata is a clinical-stage biotechnology company focused on the development of pathogen-specific bacteriophage therapeutics for the treatment of antibiotic-resistant and difficult-to-treat ...

This kit utilizes a rapid spin column method to purify total DNA from a wide range of bacteriophages cultured in liquid-grown ...

Returning to Boston this February, the Bacteriophage Therapy Summit is the only global platform for industry-dominated phage drug developers. Uniting 90+ Chief Executive Officers, Vice Presidents ...

Roth wrote that the hospital would take “corrective actions” against the two physicians — Dr. George Grammatopoulos and Dr.

In this work, a complex in vivo model of tumors accompanied by surgical wound infection was applied. Bacteriophages modified with anticancer YIGSR peptides acted as the active agents. Evaluation ...

Known as phage therapy, it uses viruses to kill harmful bacteria in difficult-to-treat infections. Read more at ...

She made headlines for groundbreaking bacteriophage (or phage) therapy treatment last year. In collaboration with the Winnipeg company Cytophage Technologies Inc., Azad made use of an old therapy ...

("Armata" or the "Company"), a clinical-stage biotechnology company focused on the development of high-purity pathogen-specific bacteriophage therapeutics for the treatment of antibiotic-resistant ...

In a growing global trend, bacteria are evolving new ways to maneuver around medical treatments for a variety of infections.